Biosimilar drugs promise to slash health-care costs in rich countries - Pill bills

in #dlike6 years ago

share-with-dlike.jpg

“IT’S THE prices, stupid.” That simple assessment of America’s wildly expensive health-care system was made 15 years ago by Uwe Reinhardt, a health economist who died last year. Health costs as a proportion of America’s economic output have soared since, from 14.5% in 2003 to over 17% in 2017, with drug-price inflation a big culprit.


Source of shared Link

Sort:  

The medicines a pharma produces is surely a big income for the manufacturer... Pharma industry is a big cash earner because the people want to become healthy at any cost.